0001562180-20-005870.txt : 20200903 0001562180-20-005870.hdr.sgml : 20200903 20200903190126 ACCESSION NUMBER: 0001562180-20-005870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200903 DATE AS OF CHANGE: 20200903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanders Dale CENTRAL INDEX KEY: 0001780970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 201160322 MAIL ADDRESS: STREET 1: C/O HEALTH CATALYST, INC. STREET 2: 3165 E. MILLROCK DRIVE #400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-09-01 false 0001636422 Health Catalyst, Inc. HCAT 0001780970 Sanders Dale C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY UT 84121 false true false false Chief Technology Officer Common Stock 2020-09-01 4 M false 27500.00 10.80 A 191984.00 D Common Stock 2020-09-01 4 S false 14090.00 31.29 D 177894.00 D Common Stock 2020-09-01 4 S false 13410.00 32.06 D 164484.00 D Stock Option (Right to Buy) 10.80 2020-09-01 4 M false 27500.00 0.00 D 2028-09-27 Common Stock 27500.00 443389.00 D The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). 25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. /s/ Daniel Orenstein, as Attorney-in-Fact 2020-09-03